When was Aldevron founded?

Aldevron was founded in 1998 and raised its 1st funding round 9 years after it was founded.

Where is Aldevron located?

Aldevron is headquartered in Fargo, United States. It is registered at Fargo, North Dakota.

How many employees does Aldevron have?

As of Aug 31, 2026, the latest employee count at Aldevron is 729.

Is Aldevron a funded company?

Aldevron is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 10, 2007.

When was the latest funding round of Aldevron?

Aldevron's latest funding was a $***** PE round on Jan 24, 2017, with participation from 1 investor.

Where does Aldevron rank among its competitors?

Aldevron ranks 20th amongst 339 active competitors, of which 22 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Abingdon Health, which secured $4.4M in Oct, 2025.

Who are the top competitors of Aldevron?

Aldevron's top competitors include Anthem Biosciences, Patheon and Aragen. Among them, Abingdon Health secured the most recent funding round in October, 2025.

Aldevron - 2026 Company Profile, Funding & Competitors

Q: Is Aldevron an acquired company?

Aldevron got acquired by Danaher on Jun 17, 2021.

Aldevron is an acquired company based in Fargo (United States), founded in 1998. It operates as a Manufacturing plasmid DNA, RNA, proteins, and enzymes for genomic medicine. Aldevron has raised an undisclosed amount in funding from TA Associates. The company has 339 active competitors, including 22 funded and 98 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and Aragen.

Company Details

Manufacturing plasmid DNA, RNA, proteins, and enzymes for genomic medicine. They offer comprehensive solutions and regulatory support for viral and non-viral vector therapies, simplifying the journey from discovery to commercialization. Services include plasmid design, process development, QC, lentiviral plasmids, nucleases, gRNA, RNA design, LNP encapsulation, and fill/finish. They provide standardized catalog products at research grade, GMP-Source™, and cGMP grade. They support gene therapy, gene-modified cell therapy, gene editing, and RNA vaccines & therapeutics. They offer custom manufacturing workflows, advanced facilities, and certifications to advance therapeutic projects. They provide high-quality biologicals for life science applications, offering contract services and expert support at every stage of development and production.

Website: www.aldevron.com/
Social
Registered Address: Fargo, North Dakota

Key Metrics

Founded Year

1998

Location

Fargo, United States

Stage

Acquired

Latest Funding Round

PE, Jan 24, 2017, $*****

Investors

TA Associates & 3 more

Ranked

20^th among 339 active competitors

Employee Count

729 as on Aug 31, 2026

Investment & Acquisitions

Genovac

Similar Companies

KBI Biopharma & 159 more

Exit Details

Acquired by Danaher (Jun 17, 2021)

View Aldevron's full profile

Aldevron is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Aldevron, Llc CIN: 450451327 , United States, Active	Dec 26, 999	-	895 (As on Dec 31, 2022)	-

Aldevron got acquired by Danaher on Jun 17, 2021 at an acquisition amount of $*****.

Click here to take a look at Aldevron's acquisition in detail

Aldevron has raised funding over 4 rounds. Its first funding round was on Aug 10, 2007. Its latest funding round was a PE round on Jan 24, 2017 for $*****. 1 investor participated in its latest round. Aldevron has 4 institutional investors.

Here is the list of recent funding rounds of Aldevron:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 24, 2017	2824865	PE	6048509	7739626	7933471	2075098
Sep 15, 2013	5953735	Grant (prize money)	4248605	6011639	8087536	HHS
Feb 20, 2009	6876579	Grant (prize money)	3365992	8386180	9478360	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Aldevron's funding rounds and investors

Aldevron's employee count trend

Aldevron has 729 employees as of Aug 26. Here is Aldevron's employee count trend over the years:

Uncover Aldevron's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Aldevron include Anthem Biosciences, Patheon and Aragen. Here is the list of Top 10 competitors of Aldevron, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Anthem Biosciences 2006, Bengaluru (India), Public	Developer of integrated contract research development and manufacturing services	$35.7M	Portsmouthtechnologiestrialsunit, True North ... & 8 others	76/100
2nd	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	Frazier Healthcare Partners, Audax Group & 3 others	74/100
3rd	Aragen 2001, Hyderabad (India), Series B	Provider of drug discovery, clinical development, manufacturing, and other services for small molecules	$161M	Goldman Sachs, Quadria Capital & 18 others	69/100
4th	KBI Biopharma 1996, Durham (United States), Acquired	Provider of protein formulation, process & cell line development, and cGMP services	$21M	Ballast Point Ventures, NCBiotech & 1 others	69/100
5th	Syngene 1993, Bengaluru (India), Public	Provider of contract research and manufacturing services for both small molecules and biologics	$85.9M	True North, Education Growth Partners & 9 others	66/100
6th	Abzena 2001, Cambridge (United Kingdom), Acquired	Provider of antibody discovery, cell line development, and bio analytics services	$67.1M	Imperial Innovations, Invesco Perpetual & 11 others	66/100
7th	Abingdon Health 2008, York (United Kingdom), Public	Developer of immunoassays for diagnostic purposes	$24.1M	Imperial Innovations, Mercia & 2 others	64/100
8th	Panacea Biotec 1984, Ambala (India), Public	Developer of biosimilars, vaccines and natural products	-	India Resurgence Fund, Department of Biotechnology ... & 1 others	62/100
9th	Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired	Aseptic manufacturing CDMO providing fill-finish services for sterile injectables	$16.9M	Municipal Employees' Retirement System, Trout Creek Ventures ... & 5 others	59/100
10th	EirGenix 2012, Taipei (Taiwan), Public	Contract development and manufacturing organization for biologics	-	CDIB Capital Group, Taiwania Capital & 3 others	58/100
20th	Aldevron 1998, Fargo (United States), Acquired	Manufacturing plasmid DNA, RNA, proteins, and enzymes for genomic medicine	-	TA Associates, Salvia & 2 others	53/100